Assay Development
Assay Development
批准号:
8379686
负责人:
Eduard A. Sergienko
金额:
$262.56万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
已结题
起止时间:
至 2014-05-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
UNIT 1. ASSAY DEVELOPMENT, ADAPTATION, AND IMPLEMENTATION
Unit 1 is a responsible for all assay activities, as well as for post-HTS hit characterization, performing: (a)
assay development and adaptation for HTS and HCS, (b) initial characterization of hits through confirmatory
assays and ECso/ICsq determination, (c) secondary and orthogonal assays and screens, (d) testing of analogs
and chemistry-optimized compounds, and (e) preliminary mode-of-action studies on hits and optimized
compounds. Unit 1 surpassed the MLSCN goals with the development and adaptation of 36 primary HTS
assays consisting of a variety of read-outs, resulting in 39 screening campaigns thus far. The Unit also
developed 27 secondary/counter assays to support the MLSCN projects. Additionally, the Unit supported 22 hit
optimization/SAR projects using 41 dose-response assays, generated >24,000 IC50 10-point curves in
duplicate and performed >20 mode-of-action studies. Unit 1 is organized into two subunits: subunit 1A will
develop and implement all HTS assays, while subunit 1B is responsible for developing and optimizing software
algorithms for HCS.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Discovery of Glutaryl-CoA Dehydrogenase inhibitors for melanoma and pancreatic cancer
-
批准号:10347030
-
项目类别:
-
资助金额:$56.99万
-
财政年份:2021
-
负责人:Eduard A. Sergienko
-
依托单位:
Discovery of Glutaryl-CoA Dehydrogenase inhibitors for melanoma and pancreatic cancer
-
批准号:10536671
-
项目类别:
-
资助金额:$59.91万
-
财政年份:2021
-
负责人:Eduard A. Sergienko
-
依托单位:
Assay Development
-
批准号:7938912
-
项目类别:
-
资助金额:$255.8万
-
财政年份:--
-
负责人:Eduard A. Sergienko
-
依托单位:
Assay Development
-
批准号:8142962
-
项目类别:
-
资助金额:$253.62万
-
财政年份:--
-
负责人:Eduard A. Sergienko
-
依托单位:
Assay Development
-
批准号:8336974
-
项目类别:
-
资助金额:$263.13万
-
财政年份:--
-
负责人:Eduard A. Sergienko
-
依托单位:
海外基金